Apheresis Market to growing at CAGR of 7.3% by 2023, Top Prominent Players: HemaCare Corporation, Kaneka Corporation

The ever increasing demand for plasma-derived biopharmaceuticals has supplemented the need for plasma components across the globe, which further propelled the growth of apheresis market. Moreover, increase in blood shortage and rise in incidence of blood disorders fuels the adoption of apheresis systems primarily across blood centers and hospitals.

Download Detailed COVID-19 Impact Sample Report at @ https://www.alliedmarketresearch.com/request-for-customization/2855?reqfor=covid

The global apheresis market generated $2.75 billion in 2017 and is expected to garner $4.20 billion by 2023, registering a CAGR of 7.3% during the forecast period, 2017-2023.

COVID-19 scenario-

1) Due to the global pandemic all over the world, the medical devices manufacturers are majorly focusing on essential medical devices production including ventilators and diagnostics.

2) However, due to the precautionary measures taken by governments in various regions, the supply chain has been hampered. Which may result in shortage of devices in certain locations.

3) Food and Drugs Administration (FDA), on the other hand, shared a COVID-19 guidance with medical device manufacturers to notify the agency about changes that could affect availability of their products.

The growth of the global apheresis market is driven by rising demand for blood components across the globe, surge in government initiatives regarding blood donation, and recently approved indications for apheresis treatment. Additionally, the increase in demand for plasma-driven pharmaceuticals is set to provide lucrative opportunities for emerging market players in the near future. However, lack of skilled professionals and complications pertaining to apheresis procedure restrain the market growth.

Download Report Sample @ https://www.alliedmarketresearch.com/request-sample/2855

By procedure, the donor/automated apheresis segment is expected to generate almost two-thirds of the global revenue by 2023, due to increase in gap between blood supply and blood products, which facilitate the need for using apheresis machines. However, the therapeutic apheresis segment is projected to register the highest CAGR of 8.3% from 2017 to 2023.

By method, the membrane separation segment is projected to grow at the fastest CAGR of 8.1% during the forecast period, due to the rise in demand for membrane separation apheresis as it prevents the need for replacement fluids by not depleting the blood coagulation factors. However, the centrifugation segment is expected to dominate the market and occupy more than two-fifths of the global market by 2023, as centrifugation is considered to be a standard method for apheresis and is highly favored by the blood industry across the globe.

Regionally, Asia-Pacific is projected to encounter the highest CAGR of 8.8% during the forecast period, on account of its high population base, upsurge in disposable income, and rise in patient awareness toward blood donation. Additionally, rise in prevalence of dengue outbreak across countries in the Asia-Pacific region would supplement future growth.

To know more about the report, visit the website at @ https://www.alliedmarketresearch.com/apheresis-market

The Major Key Players Are:

• Haemonetics Corporation
• Fresenius Kabi
• Terumo BCT, Inc.
• Asahi Kasei Medical Co., Ltd.
• HemaCare Corporation
• Kaneka Corporation
• Kawasumi Laboratories Inc.
• Cerus Corporation
• B. Braun Melsungen AG
• Nikkiso Co., Ltd.

The Other Prominent Players Are:

• Grifols International SA
• Baxter International Inc.
• CSL Behring
• Immucor, Becto
• Dickinson & Co.
• Abbott Laboratories
• Medicap
• Bioelettronica.

Similar Reports:

Ophthalmic Drugs Market : https://www.pharmiweb.com/press-release/2020-09-08/ophthalmic-drugs-market-to-grow-valuation-of-4266-billion-by-2023

Laparoscopy Devices Market : https://www.pharmiweb.com/press-release/2020-09-08/laparoscopy-devices-market-on-target-to-hit-18-90705-million-by-2027

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

About Us:

Allied Market Research (AMR) is a market research and business-consulting firm of Allied Analytics LLP, based in Portland, Oregon. AMR offers market research reports, business solutions, consulting services, and insights on markets across 11 industry verticals. Adopting extensive research methodologies, AMR is instrumental in helping its clients to make strategic business decisions and achieve sustainable growth in their market domains. We are equipped with skilled analysts and experts, and have a wide experience of working with many Fortune 500 companies and small & medium enterprises.

This release was published on openPR.